North America Joint Resurfacing Devices Market Analysis and Forecast by Size, Share, Growth, Trends 2031

The North America Joint Resurfacing Devices Market size is expected to reach US$ 1,464.1 Million by 2031 from US$ 1,047.7 Million in 2024. The market is estimated to record a CAGR of 5.0% from 2025 to 2031.

Executive Summary and North America Joint Resurfacing Devices Market Analysis:

The North America joint resurfacing devices market is segmented into the US, Canada, and Mexico. An advanced healthcare infrastructure, high prevalence of osteoarthritis among an aging population, and widespread adoption of innovative surgical technologies drive the market. The American Academy of Orthopaedic Surgeons reports that knee replacement surgeries, often incorporating resurfacing techniques, are projected to exceed 3.5 million annually by 2030 in the US alone, with resurfacing options gaining traction for younger patients seeking bone-preserving alternatives. A notable example is Smith and Nephew's OXINIUM resurfacing solution, which demonstrates a 94.1% 20-year survivorship rate and 35% fewer revisions compared to traditional metal-on-metal implants, according to industry analyses from medical device updates. Technological advancements such as robotic-assisted systems further support the market. A notable example is Stryker's Mako SmartRobotics, unveiled at the 2025 American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting, which integrates real-time guidance for hip and knee resurfacing, reducing postoperative pain and accelerating recovery. In Canada, substantial government investments in orthopedic innovations and the digitization of healthcare are expected to drive the market growth. North America's market resilience stems from robust reimbursement policies under Medicare and private insurance, covering up to 80% of resurfacing procedures for eligible patients. Additionally, over 54 million US adults have arthritis, according to Centers for Disease Control and Prevention data. Initiatives such as Zimmer Biomet's 2025 Cutting Edge Symposium on total knee and hip arthroplasty promote innovation and aim to address training gaps. The launch of 3D-printed personalized implants in September 2025 exemplifies the shift toward customized, minimally invasive solutions that enhance patient mobility and quality of life.

North America Joint Resurfacing Devices Market: Strategic Insights

North America Joint Resurfacing Devices Market Segmentation Analysis:

• By Type, the North America Joint Resurfacing Devices Market is segmented into Knee, Hip, Shoulder, Ankle, and Others. The Knee segment dominated the market in 2024.
• By Material, the North America Joint Resurfacing Devices Market is segmented into Metal, Ceramic, and Others. The Metal segment dominated the market in 2024.
• By End User, the North America Joint Resurfacing Devices Market is segmented into Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers, and Others. The Hospitals segment dominated the market in 2024.

North America Joint Resurfacing Devices Market Players Density: Understanding Its Impact on Business Dynamics

The North America Joint Resurfacing Devices Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

North America Joint Resurfacing Devices Market Outlook

The integration of artificial intelligence (AI) for predictive analytics and real-time surgical guidance is revolutionizing preoperative planning, intraoperative decision-making, and postoperative outcome forecasting. AI algorithms analyze vast datasets from imaging, patient history, and biomechanical models to simulate resurfacing procedures, optimizing implant placement, and reducing revision rates by up to 30% through enhanced alignment accuracy. For instance, Stryker's Mako system employs AI to convert preoperative CT scans into 3D joint models, guiding robotic arms in hip resurfacing with sub-millimeter precision. A 2025 study demonstrated the impact of AI-assisted procedures in shoulder resurfacing. Among 150 patients, AI achieved 98% optimal glenoid positioning compared to 82% with manual techniques. At 12-month follow-up, dislocation rates were 25% lower in the AI-assisted group. This technology mitigates risks such as aseptic loosening, a common failure mode affecting 15-20% of resurfaced joints within five years, by predicting stress distributions via machine learning models trained on over 10,000 historical cases. In knee resurfacing, AI platforms such as Enhatch enable virtual triaging. Using convolutional neural networks (CNNs), they detect early osteoarthritis from radiographs with 91% accuracy matching senior clinicians. This capability supports tailored partial resurfacing plans that preserve up to 40% more native bone. A 2025 Frontiers review of 25 peer-reviewed studies from 2024-2025 highlighted AI's role in reducing complication rates by 18% across specialties, with real-time feedback adjusting for anatomical shifts during surgery. Future expansions include AI-embedded smart implants that monitor load-bearing in vivo, alerting clinicians via apps to impending wear, potentially extending device lifespan by 20-25%. AI will democratize access to high-precision resurfacing in ambulatory centers, lowering costs by 15% through fewer revisions and enabling global scaling via cloud-based analytics. Ethical considerations, such as data privacy under GDPR-like frameworks, must evolve alongside, but AI's trajectory promises a shift from reactive to proactive resurfacing, where algorithms not only guide scalpels but also anticipate failures.

North America Joint Resurfacing Devices Market Country Insights

By country, the North America Joint Resurfacing Devices Market is segmented into the United States, Canada, and Mexico. The United States held the largest share in 2024.

The US joint resurfacing market reflects a significant aging population and rapid adoption of minimally invasive technologies designed to preserve bone stock for younger, active patients. As of 2025, hip resurfacing accounts for approximately 0.3% of all primary hip arthroplasties, based on American Joint Replacement Registry (AJRR) data covering 4.3 million hip and knee procedures from 2012 to 2023. This translates to 1,500-2,000 annual hip resurfacing surgeries, a sharp decline from 3.2% in 2012 due to concerns over metal-on-metal implant wear. However, the segment is showing signs of recovery, driven by ceramic implant innovations that address prior safety issues. The Centers for Disease Control and Prevention (CDC) reports that over 32.5 million US adults have arthritis, with knee and hip joints most affected. A high prevalence has fueled demand for resurfacing as an alternative to total joint replacement. Projections indicate that primary total hip arthroplasty volumes could increase by 75% by 2025, with resurfacing capturing a growing share among patients under 65. Key developments include. Another the HemiCAP Patello-Femoral Resurfacing Prosthesis, FDA-approved for compartmental knee resurfacing, specifically targeting isolated patellofemoral damage in active individuals. There were lower revision risks for patellar resurfacing in total knee arthroplasty cases (TKAs), where resurfaced cases showed higher survivorship than non-resurfaced ones. Regulatory oversight by the FDA ensures rigorous pre-market approvals for medical devices. For instance, the ReCerf all-ceramic hip resurfacing system received 510(k) clearance in 2024, highlighting biocompatibility and reducing concerns over metal ion release. Future growth is expected to be bolstered by robotic-assisted precision tools that reduce operative time by nearly 20%.

Thus, the US market underscores a shift toward patient-specific, durable solutions, enhancing mobility for over 450,000 annual hip procedures while addressing equity in care delivery.

North America Joint Resurfacing Devices Market Company Profiles

Some of the key players operating in the market include MicroPort Scientific Corp, Stryker Corp, Zimmer Biomet Holdings Inc, Smith & Nephew Plc, JRI Orthopaedics Limited, Enovis Corp, Medacta Group SA, Corin Group, MatOrtho Limited, and JointMedica

These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

North America Joint Resurfacing Devices Market Research Methodology

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research

The research process begins with comprehensive secondary research, utilizing internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations
• Industry trade journals and other relevant publications
• Government documents, statistical databases, and market reports
• News articles, press releases, and webcasts specific to companies operating in the market

Note:

Primary Research

The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:

• Validate and refine findings from secondary research
• Enhance the expertise and market understanding of the analysis team
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, Business Development Managers, Market Intelligence Managers, and National Sales Managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise